≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Malignant neoplasm of uterus, part unspecified, including Hilmo

Endpoint Browser

C3_UTERUS_NAS_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

only females

313377

2. Check conditions

None

313377

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C55
  • Hospital discharge: ICD-8 — 182
  • Cause of death: ICD-10 — C55
  • Cause of death: ICD-8 — 182
  • Cause of death: excluded ICD-8 — 1820
  • Cancer registry: Topography ICD-O-3 — C55
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

204

4. Check minimum number of events

None

204

5. Include endpoints

None

204

6. Filter based on genotype QC (FinnGen only)

185

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 185 185 -
Unadjusted period prevalence (%) 0.07 0.07 -
Median age at first event (years) 57.24 57.24 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
190
Matched controls
1900
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
128
Kela drug reimbursment
Cancers of female genital organs
+∞
104.0
90
*
C55
ICD-10 Finland
Malignant neoplasm of uterus, part unspecified
+∞
89.9
79
*
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
76.3
68
*
18200
ICD-8 Finland
Other malignant neoplasm of uterus, Carcinoma corporis uteri
+∞
64.3
58
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
54.9
50
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
12.3
30.7
33
32
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
27.8
26
*
H02AB02
ATC
dexamethasone; systemic
37.7
23.2
29
9
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
234.7
21.0
21
*
115
Kela drug reimbursment
Breast cancer
+∞
20.2
19
*
HA1AA
NOMESCO Finland
X-ray mammography
8.4
18.7
26
35
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
18.0
17
*
A04AA01
ATC
ondansetron; systemic, rectal
8.4
17.4
24
32
JN4BD
NOMESCO Finland
Extensive body CT
7.8
17.0
25
36
JN4AD
NOMESCO Finland
Body CT examination
6.4
16.1
29
52
130
Kela drug reimbursment
Malignant tumour
+∞
15.8
15
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
15.8
15
*
18220, ,
ICD-8 Finland
+∞
15.8
15
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
15.8
15
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
15.8
15
*
L02BG04
ATC
letrozole; oral
173.7
15.7
16
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
14.8
14
*
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
+∞
14.8
14
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
14.8
14
*
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
39.5
14.7
18
5
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
4.3
14.2
43
121
A03FA01
ATC
metoclopramide; systemic, rectal
3.7
14.0
56
192
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
13.7
13
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
12.6
12
*
A04AA02
ATC
granisetron; systemic, transdermal
138.8
12.6
13
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
138.8
12.6
13
*
B01AB10
ATC
tinzaparin; parenteral
4.4
12.6
35
92
HAB40
NOMESCO Finland
Wedge excision of mammary gland
+∞
11.6
11
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
11.6
11
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
11.6
11
*
18221, ,
ICD-8 Finland
+∞
11.6
11
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
11.6
11
*
L02BA01
ATC
tamoxifen; oral
+∞
11.6
11
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
11.6
11
*
C54.1
ICD-10 Finland
Malignant neoplasm: Endometrium
+∞
11.6
11
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
9.1
10.7
22
27
8890/3-C55.9
ICD-O-3
Leiomyosarcoma, NOS, of uterus, NOS
+∞
10.5
10
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.3
9.5
20
41
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
9.4
9
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
94.1
8.5
9
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
8.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
8.4
8
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
8.4
8
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
8.4
8
*
N95.0
ICD-10 Finland
Postmenopausal bleeding
3.0
8.1
40
153
WZC00
NOMESCO Finland
Treatment plan or consultation
2.6
8.0
60
286
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
83.2
7.5
8
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
10.0
7.4
14
15
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
L01BC06
ATC
capecitabine; oral
+∞
7.3
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.3
7
*
18202
ICD-8 Finland
Other malignant neoplasm of uterus, Sarcoma uteri
+∞
7.3
7
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.3
7
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
7.3
7
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
7.3
7
*
1820A
ICD-9 Finland
Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]
+∞
7.3
7
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
7.3
7
*
8000/3-C55.9
ICD-O-3
Neoplasm, malignant of uterus, NOS
+∞
7.3
7
*
18201
ICD-8 Finland
Other malignant neoplasm of uterus, Carcinoma corporis et cervicis uteri
+∞
7.3
7
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.3
7.1
19
48
LCD00
NOMESCO Finland
Hysterectomy
4.0
6.5
19
51
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
5.4
6.4
18
36
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
+∞
6.3
6
*
WF002
NOMESCO Finland
Radical radiotherapy
27.7
6.3
8
*
LEB00
NOMESCO Finland
Biopsy of vagina
9.1
6.2
12
14
Z2221
NOMESCO Finland
Medical doctor
2.3
6.1
61
327

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
24
21
12.90
13.75
1.7
1.4
—
—
—
0
0
86
407
3.03
12.51
2.2
1.7
—
—
—
0
0
17
9
20.57
11.82
1.1
1.0
—
—
—
0
0
32
95
3.85
9.68
4.3
1.2
6.18
2.73
ug/l
0.54
26
75
79
430
2.43
7.95
2.4
2.0
—
—
—
0
0
113
734
2.33
7.43
9.4
4.9
4.62
4.40
e9/l
0.20
91
622
98
619
2.20
6.65
2.9
2.3
—
—
estimate
—
0
0
103
721
1.94
4.76
5.7
3.4
33.99
34.90
g/l
1.10
96
653
48
263
2.10
4.40
3.5
3.4
4.33
5.13
e6/l
0.24
26
117
21
82
2.75
4.04
1.1
1.1
—
—
—
0
0
6
5
12.33
3.79
7.0
1.0
42.83
21.20
u/ml
—
6
5
84
585
1.78
3.67
5.5
4.4
132.83
155.47
e6/l
0.17
62
399
65
426
1.80
3.44
4.9
3.8
—
—
—
0
0
84
599
1.72
3.29
3.8
2.1
2.37
2.37
mmol/l
0.06
76
521
98
739
1.67
3.05
6.5
5.0
1.22
1.22
mmol/l
0.06
91
663
5
5
10.22
2.99
3.4
1.2
1.28
6.42
nmol/l
—
5
5
74
521
1.69
2.97
4.6
3.6
40.36
40.99
e6/l
0.01
57
389
108
841
1.66
2.93
7.1
5.5
1.22
1.22
mmol/l
0.12
97
726
27
140
2.08
2.83
5.4
4.7
—
—
—
0
0
62
421
1.70
2.82
10.0
4.3
—
—
—
0
0
85
628
1.64
2.80
5.0
4.6
8.75
8.75
%
0.00
74
578
65
457
1.64
2.56
4.0
3.4
0.23
0.57
e6/l
1.75
48
333
72
520
1.62
2.55
4.5
3.0
7.40
7.40
ph
0.00
54
366
84
630
1.60
2.54
5.0
4.5
2.44
2.87
%
0.94
73
579
85
640
1.59
2.53
4.9
4.6
21.75
26.33
%
3.48
77
597
84
631
1.59
2.52
5.1
4.6
0.70
0.68
%
0.08
72
576
93
717
1.58
2.49
5.0
4.6
0.17
0.19
e9/l
0.83
76
603
27
147
1.98
2.49
2.0
2.2
25.52
34.70
u/l
0.77
21
120
33
193
1.86
2.47
1.4
1.2
—
—
—
0
0
100
786
1.57
2.45
11.4
17.1
1.27
1.35
inr
0.77
83
657
82
625
1.55
2.25
4.9
4.6
62.43
58.77
%
1.90
74
588
58
410
1.60
2.20
3.7
2.4
2.52
2.47
mmol/l
1.78
52
362
128
1084
1.55
2.12
8.3
5.1
84.07
79.91
u/l
0.40
123
995
46
311
1.63
2.08
1.4
1.3
—
—
—
0
0
32
198
1.74
2.00
4.6
4.2
7.42
7.43
ph
0.05
18
112
14
64
2.28
2.00
1.3
1.2
—
—
—
0
0
28
169
1.77
1.90
1.6
1.4
—
—
—
0
0
48
335
1.58
1.90
4.0
3.1
459.41
487.76
mosm/kgh2o
0.49
41
290
19
101
1.98
1.88
4.2
5.1
95.39
94.16
%
1.13
19
101
14
66
2.21
1.87
1.4
1.3
—
—
—
0
0
87
692
1.47
1.87
5.1
4.6
0.59
0.59
e9/l
0.06
70
572
60
447
1.50
1.76
2.1
2.5
2.60
3.14
mg/l
1.39
50
378
87
699
1.45
1.74
5.1
4.6
0.04
0.04
e9/l
0.14
70
578
29
182
1.70
1.73
3.9
2.9
7.39
7.39
ph
0.17
20
117
17
90
1.98
1.71
1.4
1.6
—
—
—
0
0
88
711
1.44
1.70
5.2
4.6
3.22
1.81
e9/l
0.39
72
607
29
183
1.69
1.70
4.2
2.7
1.73
2.64
mmol/l
0.42
24
166
41
567
0.65
1.68
1.5
1.9
1.12
1.26
mmol/l
1.25
33
472
87
710
1.42
1.56
4.6
4.0
—
—
—
0
0
5
15
3.39
1.53
1.6
1.7
3385.34
65.39
u/ml
—
5
15
57
434
1.45
1.48
5.5
4.4
—
—
—
0
0
26
168
1.63
1.41
1.6
1.9
—
—
—
0
0
21
130
1.69
1.33
1.1
1.2
—
—
—
0
0
10
48
2.14
1.30
1.3
1.6
20.30
20.67
s
—
10
43
5
18
2.82
1.29
3.8
1.7
8.80
11.61
mmol/l
—
5
18
53
408
1.41
1.28
4.8
4.5
—
0.00
—
0
5
49
372
1.43
1.28
3.8
2.6
5.89
7.59
e6/l
0.86
43
337
13
70
1.92
1.27
4.0
3.5
36.79
36.91
°c
0.51
13
70
29
202
1.51
1.16
1.9
1.9
—
—
—
0
0
14
84
1.72
1.01
1.5
1.3
—
—
—
0
0
72
603
1.31
1.00
12.8
10.1
0.00
0.00
e9/l
0.66
58
480
0
29
0.00
0.98
0.0
1.7
—
—
—
0
0
14
85
1.70
0.97
6.0
5.9
14.69
15.64
%
0.74
14
80
17
110
1.60
0.94
6.5
3.9
24.69
24.73
mmol/l
0.02
17
103
16
102
1.62
0.94
1.7
1.4
—
—
—
0
0
8
42
1.94
0.90
1.1
1.2
—
—
—
0
0
6
30
2.03
0.87
1.5
1.7
2.64
5.08
mmol/24h
—
6
24
14
91
1.58
0.77
3.1
3.3
—
—
—
0
0
6
34
1.79
0.77
3.2
2.0
—
—
—
0
0
26
194
1.39
0.76
1.6
2.0
1.96
1.85
%
0.28
20
177
14
93
1.55
0.71
3.7
4.9
24.73
25.62
mmol/l
0.29
14
93
5
27
1.87
0.69
1.6
1.3
—
—
—
0
0
17
235
0.70
0.69
1.4
1.3
9.90
9.86
u/ml
—
7
81
19
256
0.71
0.67
1.6
1.4
129.60
40.75
iu/ml
—
6
85
5
28
1.81
0.66
2.2
3.5
6.92
7.96
kpa
—
5
28
21
155
1.40
0.66
4.4
3.0
118.07
86.67
ng/l
0.70
15
130
78
693
1.21
0.62
5.3
4.4
6.31
6.42
ph
0.31
44
365
20
149
1.38
0.61
1.2
2.0
73.53
71.16
e9/l
0.09
14
119
88
795
1.20
0.58
2.4
2.4
86.68
97.02
pmol/l
1.37
48
361
45
526
0.81
0.56
4.3
3.2
37.35
26.23
mg/l
0.33
31
321
9
59
1.55
0.56
3.3
3.1
1.62
1.57
mmol/l
—
9
59
61
534
1.21
0.55
1.6
1.8
21.06
21.35
nmol/l
0.04
53
452
9
64
1.43
0.52
1.1
1.2
—
—
—
0
0
46
531
0.82
0.51
4.3
3.1
5.54
5.91
mmol/l
0.38
37
441
146
1390
1.22
0.51
23.5
17.0
36.94
22.43
mg/l
4.07
133
1139
39
331
1.22
0.48
1.7
1.7
3.71
1.54
mg/l
0.73
33
259
10
68
1.50
0.48
1.8
4.6
7.41
7.42
ph
—
5
59
13
94
1.41
0.47
1.6
2.2
—
—
—
0
0
48
547
0.84
0.46
5.4
3.7
6.40
5.75
mg/mmol
0.09
31
323
94
869
1.16
0.44
5.8
4.8
0.00
0.02
estimate
0.68
20
176
73
664
1.16
0.42
3.5
3.0
219.87
94.94
ug/l
1.55
66
601
0
15
0.00
0.41
0.0
4.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
2.1
—
10.11
—
0
16
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
405.09
—
0
11
5
34
1.48
0.40
1.8
1.9
61.92
59.34
%
—
5
34
59
649
0.87
0.36
7.4
4.8
0.00
0.03
estimate
0.80
12
140
36
410
0.85
0.34
4.3
4.0
—
—
—
0
0
13
100
1.32
0.34
2.6
2.8
—
—
—
0
0
92
862
1.13
0.33
6.0
4.8
0.00
0.00
estimate
-0.00
21
184
6
46
1.31
0.33
2.5
1.3
—
—
—
0
0
7
53
1.33
0.31
3.4
3.2
8.96
7.90
mmol/l
—
7
53
132
1368
0.89
0.29
5.4
6.3
2.62
2.59
mmol/l
0.13
120
1240
90
851
1.11
0.26
6.0
4.8
0.00
0.00
estimate
-0.00
21
174
139
1346
1.12
0.25
5.9
6.1
1.89
1.96
mu/l
0.31
127
1243
6
81
0.73
0.24
1.2
1.4
—
—
—
0
0
28
247
1.16
0.24
1.6
1.3
2.41
2.49
g/l
0.09
13
128
145
1410
1.12
0.23
19.9
15.4
—
—
—
0
0
42
384
1.12
0.22
2.0
1.7
1065.03
1215.49
nmol/l
0.60
31
288
13
107
1.23
0.22
2.2
1.4
—
—
—
0
0
38
346
1.12
0.21
2.4
2.2
361.00
348.62
umol/l
0.24
30
288
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
3.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
130
1337
0.91
0.20
7.3
7.2
40.85
40.61
mmol/mol
0.10
113
1238
19
165
1.17
0.20
1.8
2.6
2.72
4.54
ug/l
0.93
14
143
33
300
1.12
0.19
1.2
1.3
0.81
1.54
u/ml
—
8
75
73
697
1.08
0.16
4.8
4.4
27.11
83.65
ng/l
0.65
59
522
42
448
0.92
0.15
6.3
4.1
0.00
0.00
estimate
-0.00
12
141
7
89
0.78
0.15
1.0
1.3
—
—
—
0
0
130
1329
0.93
0.14
4.5
5.3
4.66
4.60
mmol/l
0.26
116
1204
115
1180
0.94
0.14
5.0
4.7
15.52
15.17
pmol/l
0.79
106
1064
30
278
1.09
0.13
3.8
3.9
—
—
—
0
0
129
1312
0.95
0.09
4.4
5.2
1.60
1.58
mmol/l
0.13
112
1185
38
400
0.94
0.09
6.4
5.2
1.02
1.02
kg/l
0.70
31
272
136
1380
0.95
0.09
5.3
5.6
6.15
6.08
mmol/l
0.20
118
1239
7
65
1.08
0.08
6.7
4.9
—
—
—
0
0
6
72
0.83
0.08
1.0
1.1
—
117.44
—
0
21
15
163
0.91
0.07
2.2
2.3
0.00
0.00
estimate
—
5
32
16
173
0.92
0.07
5.1
4.0
718.13
328.48
ng/l
0.96
16
160
124
1256
0.96
0.06
4.0
4.4
1.30
1.25
mmol/l
0.44
105
1112
15
139
1.09
0.05
4.2
4.4
7.38
7.34
ph
—
8
92
10
110
0.90
0.05
8.4
3.7
—
—
—
0
0
35
363
0.96
0.05
4.9
5.0
43.46
87.03
ng/l
0.96
28
320
11
106
1.04
0.00
2.5
2.4
0.95
1.04
%
0.42
11
106
10
101
0.99
0.00
1.4
1.5
—
—
—
0
0
18
179
1.01
0.00
1.3
1.4
234.29
621.54
titre
—
7
52
11
107
1.03
0.00
1.1
1.2
—
—
—
0
0
11
107
1.03
0.00
2.6
2.4
0.82
0.63
%
0.91
11
107
49
485
1.01
0.00
6.8
4.7
0.00
0.00
estimate
-0.00
18
157
149
1488
1.01
0.00
36.2
24.9
8.08
6.81
e9/l
0.94
144
1440
149
1488
1.01
0.00
36.2
24.9
4.14
4.30
e12/l
3.49
144
1440
39
388
1.01
0.00
1.7
1.7
416.00
489.59
pmol/l
0.76
32
318
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
116.55
—
0
8
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.8
—
21.11
—
0
8
0
8
0.00
0.00
0.0
3.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
79
0.88
-0.00
3.6
1.7
11.26
10.21
g/l
—
7
74
0
5
0.00
-0.00
0.0
5.4
—
8.24
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
10.80
—
0
5
5
55
0.91
-0.00
3.2
2.8
7.42
7.41
ph
—
5
55
0
5
0.00
-0.00
0.0
1.0
—
23.00
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
1414.50
—
0
6
0
9
0.00
-0.00
0.0
1.1
—
81.11
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
53.33
—
0
6
8
84
0.95
-0.00
1.1
1.4
—
55.97
—
0
7
0
6
0.00
-0.00
0.0
4.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
80.00
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
57
0.87
-0.00
1.0
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_UTERUS_NAS_WIDE – Malignant neoplasm of uterus, part unspecified, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).